Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nishan S. Gunasekara"'
Autor:
Nishan S. Gunasekara, Julia A. Balfour
Publikováno v:
Disease Management and Health Outcomes. 5:41-54
Community-acquired pneumonia (CAP) is a common cause of morbidity and mortality and is associated with the consumption of considerable health resources worldwide. Initial treatment of patients with CAP is often empirical. Growing concern about the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d01650c0b3ac7a2ff4680d6f26e62b8
https://doi.org/10.2165/00115677-199905010-00004
https://doi.org/10.2165/00115677-199905010-00004
Autor:
Stuart Noble, Nishan S. Gunasekara
Publikováno v:
Drugs. 57:261-277
Imdur (IMD) is a sustained-release isosorbide 5-mononitrate preparation for the treatment of chronic stable angina pectoris. Controlled medication release is achieved using the Durules principle of insoluble matrix embedding. Data from randomised dou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb566ff289ac825af0c59b3505db3e14
https://doi.org/10.2165/00003495-199957020-00016
https://doi.org/10.2165/00003495-199957020-00016
Autor:
Nishan S. Gunasekara, Lynda R. Wiseman
Publikováno v:
CNS Drugs. 8:402-408
▴ Naratriptan is a new serotonin 5-HT1B/1D receptor agonist that is indicated for the acute treatment of migraine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4eefa31df3e20564a68b6a8f4a6efdfc
https://doi.org/10.2165/00023210-199708050-00006
https://doi.org/10.2165/00023210-199708050-00006
Publikováno v:
CNS drugs. 16(9)
Ziprasidone is a novel antipsychotic agent with a pharmacological profile distinct from that of other currently available novel or classical antipsychotics. In preclinical studies, ziprasidone was predicted to have efficacy against positive, negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55f90c56bb622ada2c3364150006e30b
https://pubmed.ncbi.nlm.nih.gov/12153335
https://pubmed.ncbi.nlm.nih.gov/12153335
Publikováno v:
Drugs. 62(8)
UNLABELLED Ziprasidone is a novel antipsychotic agent with a pharmacological profile distinct from that of other currently available novel or classical antipsychotics. In preclinical studies, ziprasidone was predicted to have efficacy against positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fcc1a21408448b3535b0cf9c3103389
https://pubmed.ncbi.nlm.nih.gov/12010089
https://pubmed.ncbi.nlm.nih.gov/12010089
Publikováno v:
Drugs. 58(2)
UNLABELLED Zolmitriptan is a selective serotonin 5-HT1B/1D receptor agonist ('triptan'). Its efficacy and tolerability have been assessed in a number of randomised, placebo-controlled, double-blind trials in large numbers of adults with moderate to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9688a4502db70921f452ea208ad18a12
https://pubmed.ncbi.nlm.nih.gov/10473025
https://pubmed.ncbi.nlm.nih.gov/10473025
Autor:
Diana Faulds, Nishan S. Gunasekara
Publikováno v:
Drugs. 55(3)
Raltitrexed (ZD-1694) is a quinazoline-based folate analogue that exerts its cytotoxic activity by the specific inhibition of thymidylate synthase. In vitro studies show that raltitrexed is actively transported into cells and is then rapidly and exte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4317a85a4905c4f2a3fe36489922861b
https://pubmed.ncbi.nlm.nih.gov/9530547
https://pubmed.ncbi.nlm.nih.gov/9530547
Publikováno v:
Drugs. 55(1)
Paroxetine is a potent and selective inhibitor of the neuronal reuptake of serotonin (5-hydroxytryptamine; 5-HT), which was previously reviewed as an antidepressant in Drugs in 1991. Since then, more comparative trials with other antidepressants have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21e41e8d912a92d26b4713072b4d45f1
https://pubmed.ncbi.nlm.nih.gov/9463792
https://pubmed.ncbi.nlm.nih.gov/9463792